41 related articles for article (PubMed ID: 16001464)
1. Computer-Assisted Morphometric Comparative Analysis of Argyrophilic Nucleolar Organizer Regions (AgNORs) in Leukoplakia With Dysplasia and Oral Squamous Cell Carcinoma.
Nararyanan RC; Sebastian BT; Sulaikha SH; Augustine C; Thomas T; Sudhakaran A
Cureus; 2024 Feb; 16(2):e54471. PubMed ID: 38510852
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar organizer regions in a chronic stress and oral cancer model.
Ruz IA; Ossa DA; Torres WK; Kemmerling U; Rojas BA; Martínez CA
Oncol Lett; 2012 Mar; 3(3):541-544. PubMed ID: 22740947
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the relationship between the expression of AgNOR and Ki67 with the recurrence rate in central granulomatous giant cell lesions: A case-control.
Dareh MTB; Andisheh-Tadbir A; Aghakouchakzadeh A
Clin Exp Dent Res; 2024 Apr; 10(2):e870. PubMed ID: 38506305
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of tumor-associated tissue eosinophilia and nuclear organizing region activity to validate the significance of the pattern of invasion in oral squamous cell carcinoma: A retrospective study.
Sharma HD; Mahadesh J; Monalisa W; Gopinathan PA; Laxmidevi BL; Sanjenbam N
J Oral Maxillofac Pathol; 2021; 25(2):258-265. PubMed ID: 34703119
[TBL] [Abstract][Full Text] [Related]
5. Prognostic potential of AgNORs in oral submucous fibrosis.
Murgod S; Channabasaviah GH; Shivamurthy DM; Ashok L; Krishnappa SJ
J Int Soc Prev Community Dent; 2016; 6(2):167-75. PubMed ID: 27114958
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy.
Li L; Fukumoto M; Liu D
Oncol Lett; 2013 Dec; 6(6):1611-1615. PubMed ID: 24260053
[TBL] [Abstract][Full Text] [Related]
7. A Case-Control Study of Oral Epithelial Proliferative Markers among Sudanese Toombak Dippers Using Micronuclei Assay, Argyrophilic Nucleolar Organizer Region, Papanicolaou and Crystal Violet Methods.
Anass MA; G Ahmed H
Rare Tumors; 2013; 5(3):e31. PubMed ID: 24179643
[TBL] [Abstract][Full Text] [Related]
8. Keratocystic odontogenic tumors: predictive factors of recurrence by Ki-67 and AgNOR labelling.
Selvi F; Tekkesin MS; Cakarer S; Isler SC; Keskin C
Int J Med Sci; 2012; 9(4):262-8. PubMed ID: 22639545
[TBL] [Abstract][Full Text] [Related]
9. Fluorophilia: fluorophore-containing compounds adhere non-specifically to injured neurons.
Hawkins BE; Frederickson CJ; Dewitt DS; Prough DS
Brain Res; 2012 Jan; 1432():28-35. PubMed ID: 22137653
[TBL] [Abstract][Full Text] [Related]
10. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
Derenzini M; Trerè D
Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
[TBL] [Abstract][Full Text] [Related]
11. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis].
Zaczek M
Folia Med Cracov; 1996; 37(1-2):67-88. PubMed ID: 9312528
[TBL] [Abstract][Full Text] [Related]
12. Significance of silver-stained nucleolar organizer regions in early diagnosis and prognosis of oral squamous cell carcinoma: a multivariate analysis.
Pillai KR; Sujathan K; Madhavan J; Abraham EK
In Vivo; 2005; 19(4):807-12. PubMed ID: 16001464
[TBL] [Abstract][Full Text] [Related]
13. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
[TBL] [Abstract][Full Text] [Related]
14. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
J Pathol; 1997 Aug; 182(4):450-6. PubMed ID: 9306967
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity.
Xie X; Clausen OP; Sudbö J; Boysen M
Cancer; 1997 Jun; 79(11):2200-8. PubMed ID: 9179068
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
